Neurotrophins in the ventral tegmental area: Role in social stress, mood disorders and drug abuse

Neuroscience

Volumn 282, Issue , 2014, Pages 122-138

  Nikulina, E M ^a   Johnston, C E ^a,b   Wang, J ^b,d   Hammer, Jr ^a,b,c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

BDNF; Cross sensitization; Depression; Drug abuse; Social stress

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; DOPAMINE; FIBROBLAST GROWTH FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MORPHINE; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; OPIATE; PSYCHOSTIMULANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

AVOIDANCE BEHAVIOR; BIPOLAR DISORDER; COCAINE DEPENDENCE; DEPRESSION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG EFFECT; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; ELECTROCONVULSIVE THERAPY; HUMAN; INTRACELLULAR SIGNALING; MAJOR DEPRESSION; MOOD DISORDER; MORPHINE ADDICTION; NERVE CELL PLASTICITY; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SOCIAL INTERACTION; SOCIAL STRESS; VENTRAL TEGMENTUM; ANIMAL; ANIMAL BEHAVIOR; DRUG DEPENDENCE; MENTAL STRESS; METABOLISM; PHYSIOLOGY; DISEASE PREDISPOSITION; DOPAMINE RELEASE; DRUG EXPOSURE; DRUG SENSITIZATION; FEEDING BEHAVIOR; NEUROPATHOLOGY; PROTEIN PHOSPHORYLATION; SOCIAL AVOIDANCE BEHAVIOR; SUBSTANCE ABUSE; SYNAPTIC POTENTIAL; VULNERABLE POPULATION; WEIGHT CONTROL;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; MOOD DISORDERS; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS; VENTRAL TEGMENTAL AREA;

EID: 84906314001     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.05.028     Document Type: Review

References (201)

1. Airavaara M., Pickens C.L., Stern A.L., Wihbey K.A., Harvey B.K., Bossert J.M., Liu Q.R., Hoffer B.J., Shaham Y. Endogenous GDNF in ventral tegmental area and nucleus accumbens does not play a role in the incubation of heroin craving. Addict Biol 2011, 16:261-272.
2. Altar C.A., Boylan C.B., Jackson C., Hershenson S., Miller J., Wiegand S.J., Lindsay R.M., Hyman C. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci U S A 1992, 89:11347-11351.
3. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., Lindsay R.M., Wiegand S.J. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997, 389:856-860.
4. Antelman S.M., Eichler A.J., Black C.A., Kocan D. Interchangeability of stress and amphetamine in sensitization. Science 1980, 207:329-331.
5. Babbini M., Gaiardi M., Bartoletti M. Persistence of chronic morphine effects upon activity in rats 8 months after ceasing the treatment. Neuropharmacology 1975, 14:611-614.
6. Bahi A., Boyer F., Chandrasekar V., Dreyer J.L. Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference, and reinstatement in rats. Psychopharmacology 2008, 199:169-182.
7. Bai F., Li X., Clay M., Lindstrom T., Skolnick P. Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav 2001, 70:187-192.
8. Banerjee R., Ghosh A.K., Ghosh B., Mondal A.C. Role of NGF/TrkA signaling milieu in depressogenic induction of rat brain. Al Ameen J Med Sci 2013, 6:355-363.
9. Barrot M., Sesack S.R., Georges F., Pistis M., Hong S., Jhou T.C. Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions. J Neurosci 2012, 32:14094-14101.
10. Beitner-Johnson D., Nestler E.J. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem 1991, 57:344-347.
11. Bergevin A., Girardot D., Bourque M.J., Trudeau L.E. Presynaptic mu-opioid receptors regulate a late step of the secretory process in rat ventral tegmental area GABAergic neurons. Neuropharmacology 2002, 42:1065-1078.
12. Berhow M.T., Russell D.S., Terwilliger R.Z., Beitner-Johnson D., Self D.W., Lindsay R.M., Nestler E.J. Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 1995, 68:969-979.
13. Berhow M.T., Hiroi N., Nestler E.J. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 1996, 16:4707-4715.
14. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
15. Blanchard R.J., McKittrick C.R., Blanchard D.C. Animal models of social stress: effects on behavior and brain neurochemical systems. Physiol Behav 2001, 73:261-271.
16. Blanchard R.J., Wall P.M., Blanchard D.C. Problems in the study of rodent aggression. Horm Behav 2003, 44:161-170.
17. Blochl A., Sirrenberg C. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. J Biol Chem 1996, 271:21100-21107.
18. Bolanos C.A., Perrotti L.I., Edwards S., Eisch A.J., Barrot M., Olson V.G., Russell D.S., Neve R.L., Nestler E.J. Phospholipase Cgamma in distinct regions of the ventral tegmental area differentially modulates mood-related behaviors. J Neurosci 2003, 23:7569-7576.
19. Bourdy R., Barrot M. A new control center for dopaminergic systems: pulling the VTA by the tail. Trends Neurosci 2012, 35:681-690.
20. Brown J.M., Hanson G.R., Fleckenstein A.E. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J Pharmacol Exp Ther 2001, 296:762-767.
21. Brünig I., Penschuck S., Berninger B., Benson J., Fritschy J.-M. BDNF reduces miniature inhibitory postsynaptic currents by rapid downregulation of GABAA receptor surface expression. Eur J Neurosci 2001, 13:1320-1328.
22. Cabib S., Puglisi-Allegra S. Stress, depression and the mesolimbic dopamine system. Psychopharmacology 1996, 128:331-342.
23. Cador M., Bjijou Y., Cailhol S., Stinus L. D-amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience 1999, 94:705-721.
24. Calabrese F., Molteni R., Racagni G., Riva M.A. Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 2009, 34(Suppl 1):S208-S216.
25. Carlezon W.A., Nestler E.J., Neve R.L. Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research. Crit Rev Neurobiol 2000, 14:47-67.
26. Carroll M.E., Meisch R.A. Determinants of increased drug self-administration due to food deprivation. Psychopharmacology 1981, 74:197-200.
27. Chao M.V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 2003, 4:299-309.
28. Chaudhury D., Walsh J.J., Friedman A.K., Juarez B., Ku S.M., Koo J.W., Ferguson D., Tsai H.C., Pomeranz L., Christoffel D.J., Nectow A.R., Ekstrand M., Domingos A., Mazei-Robison M.S., Mouzon E., Lobo M.K., Neve R.L., Friedman J.M., Russo S.J., Deisseroth K., Nestler E.J., Han M.H. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 2013, 493:532-536.
29. Chiodo L.A., Antelman S.M. Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment. Science 1980, 210:799-801.
30. Christie M.J. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol 2008, 154:384-396.
31. Chu N.N., Zuo Y.F., Meng L., Lee D.Y., Han J.S., Cui C.L. Peripheral electrical stimulation reversed the cell size reduction and increased BDNF level in the ventral tegmental area in chronic morphine-treated rats. Brain Res 2007, 1182:90-98.
32. Cirulli F., Alleva E. The NGF saga: from animal models of psychosocial stress to stress-related psychopathology. Front Neuroendocrinol 2009, 30:379-395.
33. Cleck J.N., Blendy J.A. Making a bad thing worse: adverse effects of stress on drug addiction. J Clin Invest 2008, 118:454-461.
34. Colussi-Mas J., Geisler S., Zimmer L., Zahm D.S., Berod A. Activation of afferents to the ventral tegmental area in response to acute amphetamine: a double-labelling study. Eur J Neurosci 2007, 26:1011-1025.
35. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 1997, 17:2295-2313.
36. Cordeira J., Rios M. Weighing in the role of BDNF in the central control of eating behavior. Mol Neurobiol 2011, 44:441-448.
37. Cordeira J.W., Frank L., Sena-Esteves M., Pothos E.N., Rios M. Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system. J Neurosci 2010, 30:2533-2541.
38. Covington H.E., Miczek K.A. Repeated social-defeat stress, cocaine or morphine. Effects on behavioral sensitization and intravenous cocaine self-administration "binges". Psychopharmacology 2001, 158:388-398.
39. Covington H.E., Tropea T.F., Rajadhyaksha A.M., Kosofsky B.E., Miczek K.A. NMDA receptors in the rat VTA: a critical site for social stress to intensify cocaine taking. Psychopharmacology 2008, 197:203-216.
40. Crooks K.R., Kleven D.T., Rodriguiz R.M., Wetsel W.C., McNamara J.O. TrkB signaling is required for behavioral sensitization and conditioned place preference induced by a single injection of cocaine. Neuropharmacology 2010, 58:1067-1077.
41. de Jong J.G., Wasilewski M., van der Vegt B.J., Buwalda B., Koolhaas J.M. A single social defeat induces short-lasting behavioral sensitization to amphetamine. Physiol Behav 2005, 83:805-811.
42. Dougherty G.G., Ellinwood E.H. Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity. Life Sci 1981, 28:2295-2298.
43. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
44. Duman R.S., Voleti B. Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci 2012, 35:47-56.
45. Eisch A.J., Bolanos C.A., de Wit J., Simonak R.D., Pudiak C.M., Barrot M., Verhaagen J., Nestler E.J. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 2003, 54:994-1005.
46. Eitan S., Bryant C.D., Saliminejad N., Yang Y.C., Vojdani E., Keith D., Polakiewicz R., Evans C.J. Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J Neurosci 2003, 23:8360-8369.
47. Fanous S., Hammer R.P., Nikulina E.M. Short- and long-term effects of intermittent social defeat stress on brain-derived neurotrophic factor expression in mesocorticolimbic brain regions. Neuroscience 2010, 167:598-607.
48. Fanous S., Lacagnina M.J., Nikulina E.M., Hammer R.P. Sensitized activation of Fos and brain-derived neurotrophic factor in the medial prefrontal cortex and ventral tegmental area accompanies behavioral sensitization to amphetamine. Neuropharmacology 2011, 61:558-564.
49. Fanous S., Terwilliger E.F., Hammer R.P., Nikulina E.M. Viral depletion of VTA BDNF in rats modulates social behavior, consequences of intermittent social defeat stress, and long-term weight regulation. Neurosci Lett 2011, 502:192-196.
50. Feder A., Nestler E.J., Charney D.S. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci 2009, 10:446-457.
51. Feng L., Wang C.Y., Jiang H., Oho C., Mizuno K., Dugich-Djordjevic M., Lu B. Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons. Brain Res Mol Brain Res 1999, 66:62-70.
52. Ferrario C.R., Robinson T.E. Amphetamine pretreatment accelerates the subsequent escalation of cocaine self-administration behavior. Eur Neuropsychopharmacol 2007, 17:352-357.
53. Ferrario C.R., Gorny G., Crombag H.S., Li Y., Kolb B., Robinson T.E. Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol Psychiatry 2005, 58:751-759.
54. Flanagin B.A., Cook E.H., de Wit H. An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response. Am J Med Genet B Neuropsychiatr Genet 2006, 141B:576-583.
55. Flores C., Rodaros D., Stewart J. Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist. J Neurosci 1998, 18:9547-9555.
56. Flores C., Samaha A.N., Stewart J. Requirement of endogenous basic fibroblast growth factor for sensitization to amphetamine. J Neurosci 2000, 20:RC55.
57. Flores J.A., Galan-Rodriguez B., Rojo A.I., Ramiro-Fuentes S., Cuadrado A., Fernandez-Espejo E. Fibroblast growth factor-1 within the ventral tegmental area participates in motor sensitizing effects of morphine. Neuroscience 2010, 165:198-211.
58. Fortin D.A., Srivastava T., Dwarakanath D., Pierre P., Nygaard S., Derkach V.A., Soderling T.R. Brain-derived neurotrophic factor activation of CaM-kinase kinase via transient receptor potential canonical channels induces the translation and synaptic incorporation of GluA1-containing calcium-permeable AMPA receptors. J Neurosci 2012, 32:8127-8137.
59. Freeman A.Y., Pierce R.C. Neutralization of neutrophin-3 in the ventral tegmental area or nucleus accumbens differentially modulates cocaine-induced behavioral plasticity in rats. Synapse 2002, 46:57-65.
60. Fumagalli F., Di Pasquale L., Caffino L., Racagni G., Riva M.A. Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. Eur J Neurosci 2007, 26:2756-2763.
61. Fumagalli F., Moro F., Caffino L., Orru A., Cassina C., Giannotti G., Di Clemente A., Racagni G., Riva M.A., Cervo L. Region-specific effects on BDNF expression after contingent or non-contingent cocaine i.v. self-administration in rats. Int J Neuropsychopharmacol 2013, 16:913-918.
62. Gall C.M., Gold S.J., Isackson P.J., Seroogy K.B. Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons. Mol Cell Neurosci 1992, 3:56-63.
63. Garzon M., Pickel V.M. Ultrastructural localization of enkephalin and mu-opioid receptors in the rat ventral tegmental area. Neuroscience 2002, 114:461-474.
64. Ghitza U.E., Zhai H., Wu P., Airavaara M., Shaham Y., Lu L. Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci Biobehav Rev 2010, 35:157-171.
65. Girault J.A., Valjent E., Caboche J., Herve D. ERK2: a logical AND gate critical for drug-induced plasticity?. Curr Opin Pharmacol 2007, 7:77-85.
66. Goggi J., Pullar I.A., Carney S.L., Bradford H.F. Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro. Brain Res 2002, 941:34-42.
67. Graham D.L., Krishnan V., Larson E.B., Graham A., Edwards S., Bachtell R.K., Simmons D., Gent L.M., Berton O., Bolanos C.A., DiLeone R.J., Parada L.F., Nestler E.J., Self D.W. Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward. Biol Psychiatry 2009, 65:696-701.
68. Grimm J.W., Hope B.T., Wise R.A., Shaham Y. Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 2001, 412:141-142.
69. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.-P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 2003, 23:742-747.
70. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J.C., Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001, 411:86-89.
71. Gulley J.M., Stanis J.J. Adaptations in medial prefrontal cortex function associated with amphetamine-induced behavioral sensitization. Neuroscience 2010, 166:615-624.
72. Gysling K., Wang R.Y. Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res 1983, 277:119-127.
73. Hall F.S., Drgonova J., Goeb M., Uhl G.R. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 2003, 28:1485-1490.
74. Hashimoto K., Shimizu E., Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004, 45:104-114.
75. Heidbreder C.A., Thompson A.C., Shippenberg T.S. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 1996, 278:490-502.
76. Horger B.A., Iyasere C.A., Berhow M.T., Messer C.J., Nestler E.J., Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 1999, 19:4110-4122.
77. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991, 350:230-232.
78. Hyman C., Juhasz M., Jackson C., Wright P., Ip N.Y., Lindsay R.M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 1994, 14:335-347.
79. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 2007, 56:27-78.
80. Iniguez S.D., Vialou V., Warren B.L., Cao J.L., Alcantara L.F., Davis L.C., Manojlovic Z., Neve R.L., Russo S.J., Han M.H., Nestler E.J., Bolanos-Guzman C.A. Extracellular signal-regulated kinase-2 within the ventral tegmental area regulates responses to stress. J Neurosci 2010, 30:7652-7663.
81. Jalabert M., Bourdy R., Courtin J., Veinante P., Manzoni O.J., Barrot M., Georges F. Neuronal circuits underlying acute morphine action on dopamine neurons. Proc Natl Acad Sci U S A 2011, 108:16446-16450.
82. Jeanneteau F., Chao M.V. Are BDNF and glucocorticoid activities calibrated?. Neuroscience 2013, 239:173-195.
83. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992, 12:483-488.
84. Johnston CE, Lasek AW, Heberlein U, Hammer RP, Jr, Nikulina EM (2011) Knockdown of ventral tegmental area mu-opioid receptors prevents social defeat stress-induced cross-sensitization to amphetamine in rats. In: 2011 Neuroscience Meeting Planner, vol. 792.04/GG14 Washington, District of Columbia: Society for Neuroscience, 2011.
85. Johnston CE, Lasek AW, Heberlein U, Hammer RP, Jr, Nikulina EM (2012) Knockdown mu-opioid receptors in the ventral tegmental area: critical effect on BDNF expression after intermittent social defeat stress. In: 2012 Neuroscience Meeting Planner, vol. 872.06/U15 New Orleans, LA: Society for Neuroscience, 2012.
86. Jones S.R., Joseph J.D., Barak L.S., Caron M.G., Wightman R.M. Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem 1999, 73:2406-2414.
87. Jovanovic J.N., Czernik A.J., Fienberg A.A., Greengard P., Sihra T.S. Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat Neurosci 2000, 3:323-329.
88. Joyce E.M., Iversen S.D. The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neurosci Lett 1979, 14:207-212.
89. Kalivas P.W., Duffy P. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Biol Psychiatry 1989, 25:913-928.
90. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 1991, 16:223-244.
91. Kang H., Schuman E.M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 1995, 267:1658-1662.
92. Kawano M., Kawasaki A., Sakata-Haga H., Fukui Y., Kawano H., Nogami H., Hisano S. Particular subpopulations of midbrain and hypothalamic dopamine neurons express vesicular glutamate transporter 2 in the rat brain. J Comp Neurol 2006, 498:581-592.
93. Kim S., Shin J.K., Yoon H.S., Kim J.H. Blockade of ERK phosphorylation in the nucleus accumbens inhibits the expression of cocaine-induced behavioral sensitization in rats. Korean J Physiol Pharmacol 2011, 15:389-395.
94. Komatsu H., Ohara A., Sasaki K., Abe H., Hattori H., Hall F.S., Uhl G.R., Sora I. Decreased response to social defeat stress in mu-opioid-receptor knockout mice. Pharmacol Biochem Behav 2011, 99:676-682.
95. Koo J.W., Mazei-Robison M.S., Chaudhury D., Juarez B., LaPlant Q., Ferguson D., Feng J., Sun H., Scobie K.N., Damez-Werno D., Crumiller M., Ohnishi Y.N., Ohnishi Y.H., Mouzon E., Dietz D.M., Lobo M.K., Neve R.L., Russo S.J., Han M.-H., Nestler E.J. BDNF is a negative modulator of morphine action. Science 2012, 338:124-128.
96. Kornetsky C. Brain-stimulation reward, morphine-induced oral stereotypy, and sensitization: implications for abuse. Neurosci Biobehav Rev 2004, 27:777-786.
97. Korsching S., Heumann R., Thoenen H., Hefti F. Cholinergic denervation of the rat hippocampus by fimbrial transection leads to a transient accumulation of nerve growth factor (NGF) without change in mRNANGF content. Neurosci Lett 1986, 66:175-180.
98. Kovalchuk Y., Hanse E., Kafitz K.W., Konnerth A. Postsynaptic induction of BDNF-mediated long-term potentiation. Science 2002, 295:1729-1734.
99. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
100. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., Laplant Q., Graham A., Lutter M., Lagace D.C., Ghose S., Reister R., Tannous P., Green T.A., Neve R.L., Chakravarty S., Kumar A., Eisch A.J., Self D.W., Lee F.S., Tamminga C.A., Cooper D.C., Gershenfeld H.K., Nestler E.J. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
101. Kudryavtseva N.N., Bondar N.P., Boyarskikh U.A., Filipenko M.L. Snca and Bdnf gene expression in the VTA and raphe nuclei of midbrain in chronically victorious and defeated male mice. PLoS ONE 2010, 5:e14089.
102. Lammel S., Ion D.I., Roeper J., Malenka R.C. Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 2011, 70:855-862.
103. Lammel S., Lim B.K., Ran C., Huang K.W., Betley M.J., Tye K.M., Deisseroth K., Malenka R.C. Input-specific control of reward and aversion in the ventral tegmental area. Nature 2012, 491:212-217.
104. Laviolette S.R., Nader K., van der Kooy D. Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav Brain Res 2002, 129:17-29.
105. Laviolette S.R., Gallegos R.A., Henriksen S.J., van der Kooy D. Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area. Nat Neurosci 2004, 7:160-169.
106. Le Foll B., Diaz J., Sokoloff P. A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. NeuroReport 2005, 16:175-178.
107. Lessmann V., Gottmann K., Heumann R. BDNF and NT-4/5 enhance glutamatergic synaptic transmission in cultured hippocampal neurones. NeuroReport 1994, 6:21-25.
108. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987, 237:1154-1162.
109. Levine E.S., Dreyfus C.F., Black I.B., Plummer M.R. Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors. Proc Natl Acad Sci U S A 1995, 92:8074-8077.
110. Li X., Wolf M.E. Brain-derived neurotrophic factor rapidly increases AMPA receptor surface expression in rat nucleus accumbens. Eur J Neurosci 2011, 34:190-198.
111. Li Y.X., Zhang Y., Lester H.A., Schuman E.M., Davidson N. Enhancement of neurotransmitter release induced by brain-derived neurotrophic factor in cultured hippocampal neurons. J Neurosci 1998, 18:10231-10240.
112. Liang J., Zheng X., Chen J., Li Y., Xing X., Bai Y., Li Y. Roles of BDNF, dopamine D3 receptors, and their interactions in the expression of morphine-induced context-specific locomotor sensitization. Eur Neuropsychopharmacol 2011, 21:825-834.
113. Liu Q.S., Pu L., Poo M.M. Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 2005, 437:1027-1031.
114. Longo F.M., Massa S.M. Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease. Nat Rev Drug Discov 2013, 12:507-525.
115. Lu L., Dempsey J., Liu S.Y., Bossert J.M., Shaham Y. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 2004, 24:1604-1611.
116. Lu L., Grimm J.W., Hope B.T., Shaham Y. Incubation of cocaine craving after withdrawal: a review of preclinical data. Neuropharmacology 2004, 47(Suppl 1):214-226.
117. Lu B., Pang P.T., Woo N.H. The yin and yang of neurotrophin action. Nat Rev Neurosci 2005, 6:603-614.
118. Lu L., Koya E., Zhai H., Hope B.T., Shaham Y. Role of ERK in cocaine addiction. Trends Neurosci 2006, 29:695-703.
119. Lu L., Wang X., Wu P., Xu C., Zhao M., Morales M., Harvey B.K., Hoffer B.J., Shaham Y. Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biol Psychiatry 2009, 66:137-145.
120. Magendzo K., Bustos G. Expression of amphetamine-induced behavioral sensitization after short- and long-term withdrawal periods: participation of mu- and delta-opioid receptors. Neuropsychopharmacology 2003, 28:468-477.
121. Marin M.T., Berkow A., Golden S.A., Koya E., Planeta C.S., Hope B.T. Context-specific modulation of cocaine-induced locomotor sensitization and ERK and CREB phosphorylation in the rat nucleus accumbens. Eur J Neurosci 2009, 30:1931-1940.
122. Martin-Iverson M.T., Todd K.G., Altar C.A. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J Neurosci 1994, 14:1262-1270.
123. Martinowich K., Manji H., Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci 2007, 10:1089-1093.
124. Mashayekhi F.J., Rasti M., Rahvar M., Mokarram P., Namavar M.R., Owji A.A. Expression levels of the BDNF gene and histone modifications around its promoters in the ventral tegmental area and locus ceruleus of rats during forced abstinence from morphine. Neurochem Res 2012, 37:1517-1523.
125. Mathon D.S., Lesscher H.M., Gerrits M.A., Kamal A., Pintar J.E., Schuller A.G., Spruijt B.M., Burbach J.P., Smidt M.P., van Ree J.M., Ramakers G.M. Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice. Neuroscience 2005, 130:359-367.
126. Matsui A., Williams J.T. Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons. J Neurosci 2011, 31:17729-17735.
127. McGeary J.E., Gurel V., Knopik V.S., Spaulding J., McMichael J. Effects of nerve growth factor (NGF), fluoxetine, and amitriptyline on gene expression profiles in rat brain. Neuropeptides 2011, 45:317-322.
128. McGough N.N.H., He D.-Y., Logrip M.L., Jeanblanc J., Phamluong K., Luong K., Kharazia V., Janak P.H., Ron D. RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J Neurosci 2004, 24:10542-10552.
129. Meredith G.E., Callen S., Scheuer D.A. Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Res 2002, 949:218-227.
130. Messer C.J., Eisch A.J., Carlezon W.A., Whisler K., Shen L., Wolf D.H., Westphal H., Collins F., Russell D.S., Nestler E.J. Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 2000, 26:247-257.
131. Miczek K.A., Nikulina E., Kream R.M., Carter G., Espejo E.F. Behavioral sensitization to cocaine after a brief social defeat stress: c-fos expression in the PAG. Psychopharmacology 1999, 141:225-234.
132. Miczek K.A., Nikulina E.M., Shimamoto A., Covington H.E. Escalated or suppressed cocaine reward, tegmental BDNF, and accumbal dopamine caused by episodic versus continuous social stress in rats. J Neurosci 2011, 31:9848-9857.
133. Molteni R., Calabrese F., Bedogni F., Tongiorgi E., Fumagalli F., Racagni G., Riva M.A. Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions. Int J Neuropsychopharmacol 2006, 9:307-317.
134. Mowla S.J., Farhadi H.F., Pareek S., Atwal J.K., Morris S.J., Seidah N.G., Murphy R.A. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 2001, 276:12660-12666.
135. Nair-Roberts R.G., Chatelain-Badie S.D., Benson E., White-Cooper H., Bolam J.P., Ungless M.A. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience 2008, 152:1024-1031.
136. Neisewander J.L., Baker D.A., Fuchs R.A., Tran-Nguyen L.T., Palmer A., Marshall J.F. Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci 2000, 20:798-805.
137. Nestler E.J. Review. Transcriptional mechanisms of addiction: role of DeltaFosB. Philos Trans R Soc Lond B Biol Sci 2008, 363:3245-3255.
138. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006, 59:1151-1159.
139. Nikulina E.M., Skrinskaya J.A., Popova N.K. Role of genotype and dopamine receptors in behaviour of inbred mice in a forced swimming test. Psychopharmacology 1991, 105:525-529.
140. Nikulina E.M., Hammer R.P., Miczek K.A., Kream R.M. Social defeat stress increases expression of mu-opioid receptor mRNA in rat ventral tegmental area. NeuroReport 1999, 10:3015-3019.
141. Nikulina E.M., Covington H.E., Ganschow L., Hammer R.P., Miczek K.A. Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: Fos in the ventral tegmental area and amygdala. Neuroscience 2004, 123:857-865.
142. Nikulina E.M., Miczek K.A., Hammer R.P. Prolonged effects of repeated social defeat stress on mRNA expression and function of mu-opioid receptors in the ventral tegmental area of rats. Neuropsychopharmacology 2005, 30:1096-1103.
143. Nikulina E.M., Arrillaga-Romany I., Miczek K.A., Hammer R.P. Long-lasting alteration in mesocorticolimbic structures after repeated social defeat stress in rats: time course of mu-opioid receptor mRNA and FosB/DeltaFosB immunoreactivity. Eur J Neurosci 2008, 27:2272-2284.
144. Nikulina E.M., Lacagnina M.J., Fanous S., Wang J., Hammer R.P. Intermittent social defeat stress enhances mesocorticolimbic DeltaFosB/BDNF co-expression and persistently activates corticotegmental neurons: implication for vulnerability to psychostimulants. Neuroscience 2012, 212:38-48.
145. Numan S., Seroogy K.B. Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J Comp Neurol 1999, 403:295-308.
146. Numan S., Lane-Ladd S.B., Zhang L., Lundgren K.H., Russell D.S., Seroogy K.B., Nestler E.J. Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal. J Neurosci 1998, 18:10700-10708.
147. Numan S., Gall C.M., Seroogy K.B. Developmental expression of neurotrophins and their receptors in postnatal rat ventral midbrain. J Mol Neurosci 2005, 27:245-260.
148. Oades R.D., Halliday G.M. Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 1987, 434:117-165.
149. Pan B., Zhong P., Sun D., Liu Q.S. Extracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects. J Neurosci 2011, 31:11244-11255.
150. Park H., Poo M.M. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 2013, 14:7-23.
151. Patterson S.L., Abel T., Deuel T.A., Martin K.C., Rose J.C., Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 1996, 16:1137-1145.
152. Paulson P.E., Camp D.M., Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology 1991, 103:480-492.
153. Perrotti L.I., Hadeishi Y., Ulery P.G., Barrot M., Monteggia L., Duman R.S., Nestler E.J. Induction of deltaFosB in reward-related brain structures after chronic stress. J Neurosci 2004, 24:10594-10602.
154. Pierce R.C., Pierce-Bancroft A.F., Prasad B.M. Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade. J Neurosci 1999, 19:8685-8695.
155. Post R.M. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 2007, 41:979-990.
156. Pu L., Q-s Liu., M-m Poo. BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat Neurosci 2006, 9:605-607.
157. Reichardt L.F. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 2006, 361:1545-1564.
158. Rios M. BDNF and the central control of feeding: accidental bystander or essential player?. Trends Neurosci 2013, 36:83-90.
159. Rivera C., Voipio J., Thomas-Crusells J., Li H., Emri Z., Sipila S., Payne J.A., Minichiello L., Saarma M., Kaila K. Mechanism of activity-dependent downregulation of the neuron-specific K-Cl cotransporter KCC2. J Neurosci 2004, 24:4683-4691.
160. Robinson T.E., Angus A.L., Becker J.B. Sensitization to stress: the enduring effects of prior stress on amphetamine-induced rotational behavior. Life Sci 1985, 37:1039-1042.
161. Roeper J. Dissecting the diversity of midbrain dopamine neurons. Trends Neurosci 2013, 36:336-342.
162. Russo S.J., Murrough J.W., Han M.H., Charney D.S., Nestler E.J. Neurobiology of resilience. Nat Neurosci 2012, 15:1475-1484.
163. Sakata K., Woo N.H., Martinowich K., Greene J.S., Schloesser R.J., Shen L., Lu B. Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex. Proc Natl Acad Sci U S A 2009, 106:5942-5947.
164. Schmidt H.D., Sangrey G.R., Darnell S.B., Schassburger R.L., Cha J.-H.J., Pierce R.C., Sadri-Vakili G. Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J Neurochem 2012, 120:202-209.
165. Schmitz Y., Lee C.J., Schmauss C., Gonon F., Sulzer D. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J Neurosci 2001, 21:5916-5924.
166. Segal R.A. Selectivity in neurotrophin signaling: theme and variations. Annu Rev Neurosci 2003, 26:299-330.
167. Seroogy K.B., Lundgren K.H., Tran T.M., Guthrie K.M., Isackson P.J., Gall C.M. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J Comp Neurol 1994, 342:321-334.
168. Sesack S.R., Pickel V.M. Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitters in the rat ventral tegmental area. Brain Res 1995, 672:261-275.
169. Sharma S., Fernandes M.F., Fulton S. Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal. Int J Obes (Lond) 2013, 37:1183-1191.
170. Sklair-Tavron L., Shi W.X., Lane S.B., Harris H.W., Bunney B.S., Nestler E.J. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A 1996, 93:11202-11207.
171. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001, 24:1217-1281.
172. Stuber G.D., Evans S.B., Higgins M.S., Pu Y., Figlewicz D.P. Food restriction modulates amphetamine-conditioned place preference and nucleus accumbens dopamine release in the rat. Synapse 2002, 46:83-90.
173. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 1982, 9:321-353.
174. Tagliaferro P., Morales M. Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic. J Comp Neurol 2008, 506:616-626.
175. Taliaz D., Nagaraj V., Haramati S., Chen A., Zangen A. Altered brain-derived neurotrophic factor expression in the ventral tegmental area, but not in the hippocampus, is essential for antidepressant-like effects of electroconvulsive therapy. Biol Psychiatry 2013, 74:305-312.
176. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 1991, 548:100-110.
177. Thoenen H. The changing scene of neurotrophic factors. Trends Neurosci 1991, 14:165-170.
178. Thomas M.J., Kalivas P.W., Shaham Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 2008, 154:327-342.
179. Tidey J.W., Miczek K.A. Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Res 1996, 721:140-149.
180. Timmusk T., Belluardo N., Metsis M., Persson H. Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues. Eur J Neurosci 1993, 5:605-613.
181. Ting A.K.R., Vargas-Perez H., Mabey J.K., Shin S.I., Steffensen S.C., van der Kooy D. Ventral tegmental area GABA neurons and opiate motivation. Psychopharmacology 2013, 227:697-709.
182. Tong Z.Y., Overton P.G., Clark D. Chronic administration of (+)-amphetamine alters the reactivity of midbrain dopaminergic neurons to prefrontal cortex stimulation in the rat. Brain Res 1995, 674:63-74.
183. Trigo J.M., Martin-Garcia E., Berrendero F., Robledo P., Maldonado R. The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend 2010, 108:183-194.
184. Tsai S.J. Increased central brain-derived neurotrophic factor activity could be a risk factor for substance abuse: Implications for treatment. Med Hypotheses 2007, 68:410-414.
185. Valjent E., Pages C., Herve D., Girault J.A., Caboche J. Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 2004, 19:1826-1836.
186. Valjent E., Corvol J.C., Trzaskos J.M., Girault J.A., Herve D. Role of the ERK pathway in psychostimulant-induced locomotor sensitization. BMC Neurosci 2006, 7:20.
187. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 2000, 151:99-120.
188. Vargas-Perez H., Ting A.K.R., Walton C.H., Hansen D.M., Razavi R., Clarke L., Bufalino M.R., Allison D.W., Steffensen S.C., van der Kooy D. Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats. Science 2009, 324:1732-1734.
189. Vezina P., Stewart J. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res 1990, 516:99-106.
190. Vezina P., Kalivas P.W., Stewart J. Sensitization occurs to the locomotor effects of morphine and the specific μ opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res 1987, 417:51-58.
191. Wake H., Watanabe M., Moorhouse A.J., Kanematsu T., Horibe S., Matsukawa N., Asai K., Ojika K., Hirata M., Nabekura J. Early changes in KCC2 phosphorylation in response to neuronal stress result in functional downregulation. J Neurosci 2007, 27:1642-1650.
192. Walsh J.J., Friedman A.K., Sun H., Heller E.A., Ku S.M., Juarez B., Burnham V.L., Mazei-Robison M.S., Ferguson D., Golden S.A., Koo J.W., Chaudhury D., Christoffel D.J., Pomeranz L., Friedman J.M., Russo S.J., Nestler E.J., Han M.H. Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway. Nat Neurosci 2014, 17:27-29.
193. Wang J, Bastle R, Bass CE, Hammer RP, Jr, Neisewander JL, Nikulina EM (2013a) BDNF over-expression in the ventral tegmental area potentiates intermittent social defeat stress-induced escalation of cocaine self-administration. In: 2013 Neuroscience Meeting Planner, 350.01/OO7 San Diego, CA: Society for Neuroscience, 2013.
194. Wang J., Fanous S., Terwilliger E.F., Bass C.E., Hammer R.P., Nikulina E.M. BDNF overexpression in the ventral tegmental area prolongs social defeat stress-induced cross-sensitization to amphetamine and increases DeltaFosB expression in mesocorticolimbic regions of rats. Neuropsychopharmacology 2013, 38:2286-2296.
195. Wang J., Bina R.W., Wingard J.C., Terwilliger E.F., Hammer R.P., Nikulina E.M. Knockdown of tropomyosin-related kinase B receptor expression in the nucleus accumbens shell prevents intermittent social defeat stress-induced cross-sensitization to amphetamine in rats. Eur J Neurosci 2014, 39:1009-1017.
196. Wardle R.A., Poo M.-M. Brain-derived neurotrophic factor modulation of gabaergic synapses by postsynaptic regulation of chloride transport. J Neurosci 2003, 23:8722-8732.
197. Weeks J.R. Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats. Science 1962, 138:143-144.
198. Willner P. Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res 1983, 287:211-224.
199. Yamaguchi T., Sheen W., Morales M. Glutamatergic neurons are present in the rat ventral tegmental area. Eur J Neurosci 2007, 25:106-118.
200. Yamaguchi T., Wang H.L., Li X., Ng T.H., Morales M. Mesocorticolimbic glutamatergic pathway. J Neurosci 2011, 31:8476-8490.
201. Zacharko R.M., Anisman H. Stressor-induced anhedonia in the mesocorticolimbic system. Neurosci Biobehav Rev 1991, 15:391-405.